BELZUTIFAN

1777 reported adverse events

Drug classes: Hypoxia-inducible Factor Inhibitor [EPC]

These side effects are most commonly reported by patients taking BELZUTIFAN:

# Side effect Count
0 ANAEMIA 329
1 MALIGNANT NEOPLASM PROGRESSION 262
2 HYPOXIA 174
3 FATIGUE 129
4 DEATH 80
5 DYSPNOEA 70
6 DIARRHOEA 66
7 HAEMOGLOBIN DECREASED 65
8 OFF LABEL USE 65
9 OXYGEN SATURATION DECREASED 61
See all common reactions for BELZUTIFAN

BELZUTIFAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HAEMANGIOBLASTOMA 4 0.0833
1 VASCULAR GRAFT OCCLUSION 27 0.0703
2 BLOOD ERYTHROPOIETIN DECREASED 2 0.0345
3 MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL 2 0.0164
4 INTRACRANIAL TUMOUR HAEMORRHAGE 6 0.0155
5 DRUG THERAPY 5 0.0147
6 AUTOIMMUNE MYOCARDITIS 2 0.0091
7 ANORECTAL INFECTION 2 0.0079
8 SPINAL CORD HAEMORRHAGE 3 0.0075
9 HYDROCEPHALUS 28 0.0051
See all enriched reactions for BELZUTIFAN